Clinical decision support

Guidelines & calculators

Practice guidelines and risk calculators

Third-party guidelines and prediction tools relevant to IBD surgery, each independently verified against PubMed. These are external documents and tools, linked, not reproduced, and not evidence-gated by this site.

Read the access and validation labels. Very few published IBD prediction tools are simultaneously a live free calculator, externally validated, and validated for the decision you are about to make. Where a tool is formula-only, or was validated only in its derivation cohort, that is stated rather than hidden behind a link. 2 further item(s) found by this review are withheld pending clinician sign-off rather than published unverified.

Practice guidelines

Risk calculators and prediction tools

  • ACS NSQIP Surgical Risk Calculator (v4.0.4) live calculatorexternally validated30-day risk of death and ~15 postoperative complications for a specified CPT procedure · PMID 24055383 Note: It has been formally externally validated in IBD surgery and it FAILED. Lin et al. (J Crohns Colitis 2023;17(1):73-82; PMID 35973971) found c-statistics of 0.605 any complication, 0.623 serious complication, 0.590 reoperation, 0.621 readmission, 0.574 anastomotic leak, with systematic UNDERESTIMATION of risk. Discrimination is barely above chance in IBD. Do not quote its absolute percentages to an IBD patient; the authors call for recalibration or added variables. This is the only free web tool covering IBD operations, which is exactly why the failure needs to be stated on the page.
  • Travis (Oxford) criteria, day 3 of acute severe ulcerative colitis live calculatorexternally validatedPredicts failure of intravenous corticosteroids at day 3 of an ASUC admission, triggering rescue therapy or colectomy discussion Note: Derived 1996 from 48 patients. Its original 85% same-admission colectomy PPV is OBSOLETE. In the biologic era, observed in-hospital colectomy among Oxford-positive patients is roughly 20–36%. It remains a valid discriminator of steroid non-response (independent predictor, and meta-analytic OR ~4.4 for colectomy), so use it to trigger a rescue-therapy decision, never to quote a colectomy probability to a patient. Derivation PMID left blank. The original 1996 Gut record was not independently verified and was not guessed.
  • ASUC 1-year colectomy score (Le Baut / Saint-Antoine IBD Network) formula only, no calculatorexternally validatedRisk of colectomy within 1 year of admission for acute severe ulcerative colitis, from four variables available at admission · PMID 31927106 Note: Genuinely validated in a separate 185-patient cohort at two other French centres, but there is NO web implementation, it must be scored by hand. Both cohorts are retrospective, French, and from 2002–2017, i.e. before JAK inhibitors and S1P modulators changed rescue therapy. The extreme strata rest on very small numbers (score 4 = 100% colectomy), so the upper end is imprecise; its real strength is as a negative predictor (NPV 87–92% for score 0).
  • Postdischarge VTE risk calculator for IBD surgery (Schlick et al.) formula only, no calculatorderivation cohort only30-day post-discharge venous thromboembolism risk after surgery for IBD · PMID 33077197 Note: DERIVATION ONLY, no external validation and no published web implementation. Built on ACS NSQIP colectomy/proctectomy targeted modules 2012–2018 (n=18,990) with a very rare outcome: 199 events (1.1%), so estimates are unstable in the tails. Do not use it as the sole justification for or against extended prophylaxis; pair it with the ASCRS 2023 VTE guideline, which is the graded recommendation.
  • Postoperative Crohn's disease recurrence nomogram (biologic era) formula only, no calculatorexternally validated1-year endoscopic recurrence (modified Rutgeerts score ≥i2b) after ileocolonic resection for Crohn's disease Note: Externally validated in two independent international cohorts, but AUC is only 0.72, adequate for group-level stratification, weak for individual prediction. No web implementation; nomogram lives in the paper. PMID was not retrievable at time of search (published online ~March 2026), cite by DOI and re-check before publishing. Note the paper's own headline result is that biologic prophylaxis reduced recurrence (OR 0.31) irrespective of risk factors, which argues against using the score to withhold prophylaxis from low-risk patients.